Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Spotify Technology (SPOT) vs Zoetis Inc (ZTS) Price & Performance

Spotify TechnologyTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Spotify Technology vs Zoetis Inc — how do they compare? Spotify Technology trades at $523.01 (market cap $107.52B), while Zoetis Inc trades at $73.83 (market cap $30.29B). The key difference: Spotify Technology is far larger — about 3.5× Zoetis Inc's market cap, and Zoetis Inc pays a 2.89% dividend while Spotify Technology pays none. Which is the better fit depends on your goals.

SPOTZTS
Market Cap
$107.52B$30.29B
Sector
MediaHealth
52-Week High
$738.53$150.61
52-Week Low
$412.75$71.91
Enterprise Value
$97.15B$37.86B
Dividend Yield
2.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Spotify Technology

Spotify (SPOT) trades at $528.64, down 2.54% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bullish trend in moving averages but neutral oscillators, with key support at $524 and resistance at $535. Fundamentally, the company reported strong revenue growth to $17.19B in 2025 and a net income margin of 12.87%, though it missed Q2 2026 EPS estimates. Recent news highlights a $1.5B share repurchase program expansion and initiatives to label AI-generated content.

The outlook for SPOT is supported by robust earnings growth, cash flow generation, and analyst optimism, with a consensus price target of $590.29. However, risks include premium valuation multiples, competitive pressures in audio streaming, and execution challenges in sustaining high growth rates. Investor sentiment remains positive given institutional buy ratings, but volatility may persist near-term.

Zoetis Inc

Zoetis (ZTS) trades at $73.6, down 2.92% on the day, near its 52-week low amid bearish technical signals. The stock shows strong fundamentals with a P/E of 12, net margin of 27.69%, and consistent earnings beats, but faces headwinds from weak U.S. companion animal sales and reduced 2026 guidance. Recent news includes an FDA emergency use authorization for Simparica Trio and participation in healthcare conferences.

The outlook is mixed: valuation appears attractive with a consensus price target of $93.40, but near-term risks include competitive pressures and soft pet health demand. Long-term investors may find value in its profitability and market dominance, though volatility persists from sector challenges and investor sentiment shifts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Spotify Technology

Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.

Read more on SPOT

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS